GeneDx Holdings Corp.WGSNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank67
3Y CAGR-10.9%
5Y CAGR+7.9%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-10.9%/yr
Annual compound
5Y CAGR
+7.9%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$239.22M+42.0%
2024$168.48M-13.5%
2023$194.71M-42.4%
2022$338.24M+6.1%
2021$318.73M+94.4%
2020$163.93M+138.1%
2019$68.84M-